Column Group III, LP

CIK 0001668159

10% Owner

Filings

Latest Feb 26, 2026

Issuers covered

Showing

35 of 35

Page 1

Track record

44 of 98 open-market trades scored (45% price coverage) - 54 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	44	48%	+5.5%	-4.9%	+78.3%	-25.3%
90 days	44	55%	+22.8%	+19.8%	+183.5%	-47.1%
180 days	20	75%	+47.8%	+23.5%	+153.0%	-51.9%
365 days	14	64%	+54.4%	+38.4%	+162.7%	-83.3%

Issuers

Companies where Column Group III, LP has filed

Ticker	Issuer	Filings	Last filed
NGM	Ngm Biopharmaceuticals Inc	18	Apr 8, 2024
TNYA	Tenaya Therapeutics, Inc.	9	Feb 26, 2026
SRZN	Surrozen, Inc./De	8	Jan 20, 2026

All filings

35 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Feb 26, 2026	TNYATenaya Therapeutics, Inc.	SSale	1,862,545	$0.5624	$1,047,495
Feb 24, 2026	TNYATenaya Therapeutics, Inc.	SSale	277,769	$0.6149	$170,800
Feb 12, 2026	TNYATenaya Therapeutics, Inc.	SSale	2,151,458	$0.6808	$1,464,713
Jan 20, 2026	SRZNSurrozen, Inc./De	PPurchase	9,568	$19.5999	$187,532
Jan 15, 2026	SRZNSurrozen, Inc./De	PPurchase	6,609	$19.8041	$130,885
Jan 8, 2026	SRZNSurrozen, Inc./De	PPurchase	8,003	$19.8872	$159,157
Dec 8, 2025	SRZNSurrozen, Inc./De	PPurchase	16,381	$19.5409	$320,099
Nov 17, 2025	SRZNSurrozen, Inc./De	PPurchase	167,307	$12.65	$2,116,434
Mar 28, 2025	SRZNSurrozen, Inc./De	PPurchase	365,769	$11.60	$4,242,920
Mar 7, 2025	TNYATenaya Therapeutics, Inc.	PPurchase	35,714,284	$0.70	$24,999,999
Apr 17, 2024	SRZNSurrozen, Inc./DeA	PPurchase	102,651	$15.50	$1,591,091
Apr 8, 2024	NGMNgm Biopharmaceuticals Inc	DDisposition	949,862	-	-
Apr 8, 2024	SRZNSurrozen, Inc./De	PPurchase	102,651	$15.50	$1,591,091
Feb 14, 2024	TNYATenaya Therapeutics, Inc.	PPurchase	2,222,222	$4.50	$9,999,999
Nov 17, 2023	NGMNgm Biopharmaceuticals Inc	PPurchase	16,791	$0.7075	$11,880
Mar 14, 2023	TNYATenaya Therapeutics, Inc.	PPurchase	6,779	$2.5956	$17,596
Feb 10, 2023	TNYATenaya Therapeutics, Inc.	PPurchase	1,500,000	$2.60	$3,900,000
Feb 1, 2023	NGMNgm Biopharmaceuticals Inc	PPurchase	176,730	$4.9986	$883,403
Jan 25, 2023	NGMNgm Biopharmaceuticals Inc	PPurchase	9,900	$4.9994	$49,494
Jan 23, 2023	NGMNgm Biopharmaceuticals Inc	PPurchase	37,639	$4.9976	$188,105
Jan 23, 2023	TNYATenaya Therapeutics, Inc.	PPurchase	69,739	$2.4979	$174,201
Jan 19, 2023	TNYATenaya Therapeutics, Inc.	PPurchase	135,688	$2.5163	$341,432
Jan 17, 2023	NGMNgm Biopharmaceuticals Inc	PPurchase	5,378	$4.9466	$26,603
Jan 12, 2023	NGMNgm Biopharmaceuticals Inc	PPurchase	209,000	$4.76	$994,840
Jun 13, 2022	NGMNgm Biopharmaceuticals Inc	PPurchase	951,684	$13.50	$12,847,734
Jun 6, 2022	NGMNgm Biopharmaceuticals Inc	PPurchase	33,071	$13.0333	$431,024
Jun 2, 2022	NGMNgm Biopharmaceuticals Inc	PPurchase	88,964	$13.45	$1,196,566
May 31, 2022	NGMNgm Biopharmaceuticals Inc	PPurchase	19,534	$13.4935	$263,582
May 26, 2022	NGMNgm Biopharmaceuticals Inc	PPurchase	41,863	$13.4349	$562,425
May 23, 2022	NGMNgm Biopharmaceuticals Inc	PPurchase	19,984	$13.2547	$264,882
May 19, 2022	NGMNgm Biopharmaceuticals Inc	PPurchase	86,110	$13.4171	$1,155,346
May 17, 2022	NGMNgm Biopharmaceuticals Inc	PPurchase	32,072	$12.9015	$413,777
May 13, 2022	NGMNgm Biopharmaceuticals Inc	PPurchase	79,945	$11.6211	$929,049
May 11, 2022	NGMNgm Biopharmaceuticals Inc	PPurchase	80,430	$10.7929	$868,073
Jan 26, 2022	NGMNgm Biopharmaceuticals Inc	PPurchase	241,750	-	-

Showing 1-35 of 35

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value